William Blair & Company
JAZZ icon

William Blair & Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

William Blair & Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339K Buy
1,791
+45
+3% +$7.86K ﹤0.01% 1286
2025
Q4 		$297K Sell
1,746
-361
-17% -$55.3K ﹤0.01% 1315
2025
Q3 		$278K Buy
2,107
+101
+5% +$12.1K ﹤0.01% 1334
2025
Q2 		$213K Sell
2,006
-549
-21% -$59.6K ﹤0.01% 1400
2025
Q1 		$317K Buy
2,555
+24
+0.9% +$3.13K ﹤0.01% 1242
2024
Q4 		$312K Buy
2,531
+509
+25% +$60K ﹤0.01% 1267
2024
Q3 		$225K Sell
2,022
-55
-3% -$6.03K ﹤0.01% 1394
2024
Q2 		$222K Sell
2,077
-10
-0.5% -$1.1K ﹤0.01% 1373
2024
Q1 		$251K Buy
2,087
+10
+0.5% +$1.23K ﹤0.01% 1324
2023
Q4 		$255K Hold
2,077
– – ﹤0.01% 1313
2023
Q3 		$269K Sell
2,077
-19
-0.9% -$2.53K ﹤0.01% 1284
2023
Q2 		$260K Buy
+2,096
New +$282K ﹤0.01% 1306
2019
Q3 		– Sell
-2,256
Closed -$322K – 1725
2019
Q2 		$322K Buy
2,256
+451
+25% +$60.6K ﹤0.01% 1131
2019
Q1 		$258K Sell
1,805
-183
-9% -$23.9K ﹤0.01% 1202
2018
Q4 		$246K Buy
1,988
+50
+3% +$7.42K ﹤0.01% 1160
2018
Q3 		$326K Hold
1,938
– – ﹤0.01% 1109
2018
Q2 		$334K Hold
1,938
– – ﹤0.01% 1070
2018
Q1 		$293K Hold
1,938
– – ﹤0.01% 1075
2017
Q4 		$261K Hold
1,938
– – ﹤0.01% 1170
2017
Q3 		$283K Buy
+1,938
New +$293K ﹤0.01% 1131
2014
Q3 		– Sell
-1,865
Closed -$274K – 2136
2014
Q2 		$274K Sell
1,865
-2,680
-59% -$372K ﹤0.01% 1839
2014
Q1 		$630K Buy
+4,545
New +$684K ﹤0.01% 1553

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

William Blair & Company's JAZZ Position: Q1 2026 in Review

William Blair & Company increased its Jazz Pharmaceuticals (JAZZ) stake by 2.6% in Q1 2026, buying an estimated $7.86K and bringing the position to 1,791 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

William Blair & Company first reported a position in JAZZ in Q1 2014 and has held it in 22 quarters since. The position peaked at $630K in Q1 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • William Blair & Company held 1,791 shares of Jazz Pharmaceuticals worth $339K as of Q1 2026.
  • William Blair & Company bought 45 Jazz Pharmaceuticals shares in Q1 2026, an estimated $7.86K.
  • Jazz Pharmaceuticals made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1286 holding.
  • William Blair & Company first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 22 quarters since.
  • William Blair & Company's Jazz Pharmaceuticals position peaked at $630K in Q1 2014.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.